Ritts RE - Search Results

1

CA 19-9 in pancreatic cancer.

Ritts RE, Pitt HA. Ritts RE, et al. Surg Oncol Clin N Am. 1998 Jan;7(1):93-101. Surg Oncol Clin N Am. 1998. PMID: 9443988 Review.

2

Comparison of portal and peripheral blood levels of carcinoembryonic antigen, CA 19-9, and CA 125 tumor-associated antigens in patients with colorectal and pancreatic cancer.

Talbot RW, Nagorney DM, Pemberton JH, Wieand HS, Ritts RE Jr. Talbot RW, et al. Among authors: ritts re jr. Cancer Res. 1989 Feb 1;49(3):542-3. Cancer Res. 1989. PMID: 2910474 Free article.

3

Comparison of preoperative serum CA19-9 levels with results of diagnostic imaging modalities in patients undergoing laparotomy for suspected pancreatic or gallbladder disease.

Ritts RE Jr, Nagorney DM, Jacobsen DJ, Talbot RW, Zurawski VR Jr. Ritts RE Jr, et al. Pancreas. 1994 Nov;9(6):707-16. doi: 10.1097/00006676-199411000-00006. Pancreas. 1994. PMID: 7846013

4

Diagnostic role of serum CA 19-9 for cholangiocarcinoma in patients with primary sclerosing cholangitis.

Nichols JC, Gores GJ, LaRusso NF, Wiesner RH, Nagorney DM, Ritts RE Jr. Nichols JC, et al. Among authors: ritts re jr. Mayo Clin Proc. 1993 Sep;68(9):874-9. doi: 10.1016/s0025-6196(12)60696-x. Mayo Clin Proc. 1993. PMID: 8396700

5

Temporary elevation of CA 125 after abdominal surgical treatment for benign disease and cancer.

Talbot RW, Jacobsen DJ, Nagorney DM, Malkasian GD, Ritts RE Jr. Talbot RW, et al. Among authors: ritts re jr. Surg Gynecol Obstet. 1989 May;168(5):407-12. Surg Gynecol Obstet. 1989. PMID: 2711294

6

Preoperative evaluation of serum CA 125 levels in premenopausal and postmenopausal patients with pelvic masses: discrimination of benign from malignant disease.

Malkasian GD Jr, Knapp RC, Lavin PT, Zurawski VR Jr, Podratz KC, Stanhope CR, Mortel R, Berek JS, Bast RC Jr, Ritts RE. Malkasian GD Jr, et al. Among authors: ritts re. Am J Obstet Gynecol. 1988 Aug;159(2):341-6. doi: 10.1016/s0002-9378(88)80081-4. Am J Obstet Gynecol. 1988. PMID: 2457318

7

Initial clinical evaluation of an immunoradiometric assay for CA 19-9 using the NCI serum bank.

Ritts RE Jr, Del Villano BC, Go VL, Herberman RB, Klug TL, Zurawski VR Jr. Ritts RE Jr, et al. Int J Cancer. 1984 Mar 15;33(3):339-45. doi: 10.1002/ijc.2910330310. Int J Cancer. 1984. PMID: 6199316

8

CA 125 in gynecologic practice.

Malkasian GD Jr, Podratz KC, Stanhope CR, Ritts RE Jr, Zurawski VR Jr. Malkasian GD Jr, et al. Among authors: ritts re jr. Am J Obstet Gynecol. 1986 Sep;155(3):515-8. doi: 10.1016/0002-9378(86)90269-3. Am J Obstet Gynecol. 1986. PMID: 2428248

9

An initial analysis of preoperative serum CA 125 levels in patients with early stage ovarian carcinoma.

Zurawski VR Jr, Knapp RC, Einhorn N, Kenemans P, Mortel R, Ohmi K, Bast RC Jr, Ritts RE Jr, Malkasian G. Zurawski VR Jr, et al. Among authors: ritts re jr. Gynecol Oncol. 1988 May;30(1):7-14. doi: 10.1016/0090-8258(88)90039-x. Gynecol Oncol. 1988. PMID: 2452773

10

Nonspecific immune determinants in the patient with unresectable gastrointestinal carcinoma.

Moertel CG, Ritts RE Jr, O'Connell MJ, Silvers A. Moertel CG, et al. Among authors: ritts re jr. Cancer. 1979 Apr;43(4):1483-92. doi: 10.1002/1097-0142(197904)43:4<1483::aid-cncr2820430440>3.0.co;2-y. Cancer. 1979. PMID: 376093

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results